{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:52:35Z","timestamp":1791168755966,"version":"4.1.0"},"reference-count":26,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recently, a novel mechanism introducing genetic instability, termed aberrant somatic hypermutation (ASHM), has been described in diffuse large B-cell lymphoma. To further investigate whether ASHM also occurs in mucosa-associated lymphoid tissue type (MALT) lymphoma, we studied the mutation profile of PIM1, PAX5, RhoH\/TTF, and c-MYC in 17 MALT lymphomas and 17 extranodal diffuse large B-cell lymphomas (DLBCLs) still exhibiting a low-grade MALT lymphoma component (transformed MALT lymphoma). Mutations in one or more genes were detected in 13 (76.5%) of 17 cases of MALT lymphomas and in all of 17 (100%) cases of extranodal DLBCL. A total of 100 sequence variants were found in 30 of 34 cases, 28 in the MALT lymphomas and 72 in extranodal DLBCL. Further, in PIM1 and c-MYC some of the mutations were found to affect coding exons, leading to amino acid exchanges, thus potentially altering gene function. Expression levels of activation-induced cytidine deaminase (AID), an enzyme essential for somatic hypermutation (SHM), was associated with the mutational load. These data indicate that aberrant SHM is associated with extranodal DLBCL and MALT lymphoma, likewise. By mutating regulatory and coding sequences of the targeted genes, ASHM may represent a major contributor to their pathogenesis.<\/jats:p>","DOI":"10.1182\/blood-2006-06-030494","type":"journal-article","created":{"date-parts":[[2006,12,29]],"date-time":"2006-12-29T20:13:08Z","timestamp":1167423188000},"page":"3500-3504","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":64,"title":["MALT lymphoma and extranodal diffuse large B-cell lymphoma are targeted by aberrant somatic hypermutation"],"prefix":"10.1182","volume":"109","author":[{"given":"Alexander J. A.","family":"Deutsch","sequence":"first","affiliation":[{"name":"Division of Haematology, Medical University Graz, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariane","family":"Aigelsreiter","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical University, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp B.","family":"Staber","sequence":"additional","affiliation":[{"name":"Division of Haematology, Medical University Graz, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Beham","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical University, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Linkesch","sequence":"additional","affiliation":[{"name":"Division of Haematology, Medical University Graz, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Guelly","sequence":"additional","affiliation":[{"name":"Centre for Medical Research, Medical University Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth I.","family":"Brezinschek","sequence":"additional","affiliation":[{"name":"Division of Haematology, Medical University Graz, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margareta","family":"Fruhwirth","sequence":"additional","affiliation":[{"name":"Division of Haematology, Medical University Graz, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Emberger","sequence":"additional","affiliation":[{"name":"Institute of Medical Biology and Human Genetics, Medical University, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Buettner","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Friedrich-Alexander-Universita\u0308t, Erlangen, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Beham-Schmid","sequence":"additional","affiliation":[{"name":"Institute of Pathology, Medical University, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Neumeister","sequence":"additional","affiliation":[{"name":"Division of Haematology, Medical University Graz, Graz, Austria;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2006,12,29]]},"reference":[{"key":"2019111715212156400_B1","doi-asserted-by":"crossref","unstructured":"Isaacson PG. Gastric MALT-lymphoma: from concept to cure. Ann Oncol1999; 10:637\u201345.","DOI":"10.1023\/A:1008396618983"},{"key":"2019111715212156400_B2","doi-asserted-by":"crossref","unstructured":"Isaacson PG and Du MQ. MALT lymphoma: from morphology to molecules [review]. Nat Rev Cancer2004; 4:644\u2013653.","DOI":"10.1038\/nrc1409"},{"key":"2019111715212156400_B3","doi-asserted-by":"crossref","unstructured":"Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas, I: gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol1997; 8:727\u2013737.","DOI":"10.1023\/A:1008282818705"},{"key":"2019111715212156400_B4","doi-asserted-by":"crossref","unstructured":"Zucca E, Roggero E, Bertoni F, Conconi A, Cavalli F. Primary extranodal non-Hodgkin's lymphomas, II: head and neck, central nervous system and other less common sites. Ann Oncol1999; 10:1023\u20131033.","DOI":"10.1023\/A:1008313229892"},{"key":"2019111715212156400_B5","unstructured":"Dogan A, Du M, Koulis A, Briskin MJ, Isaacson PG. Expression of lymphocyte homing receptors and vascular addressins in low-grade gastric B-cell lymphomas of mucosa associated lymphoid tissue. Am J Pathol1997; 151:1361\u20131369."},{"key":"2019111715212156400_B6","unstructured":"World Health Organization classification of tumours pathology and genetics of tumours of Haematopoietic and Lymphoid tissues. In Jaffe ES, Harris NL, Stein H, Vardiman JW (Eds.). Lyon2001;France IARC Press."},{"key":"2019111715212156400_B7","doi-asserted-by":"crossref","unstructured":"Streubel B, Simonitsch-Klupp I, Mullauer L, et al. Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites. Leukemia2004; 18:1722\u20131726.","DOI":"10.1038\/sj.leu.2403501"},{"key":"2019111715212156400_B8","doi-asserted-by":"crossref","unstructured":"Pasqualucci L, Neumeister P, Goossens T, et al. Hypermutation of multiple proto-oncogenes in B-cell diffuse large-cell lymphomas. Nature2001; 412:341\u2013346.","DOI":"10.1038\/35085588"},{"key":"2019111715212156400_B9","doi-asserted-by":"crossref","unstructured":"Muramatsu M, Kinoshita K, Fagarasan S, Yamada S, Shinkai Y, Honjo T. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell2000; 102:553\u2013563.","DOI":"10.1016\/S0092-8674(00)00078-7"},{"key":"2019111715212156400_B10","unstructured":"Chan JK, Ng CS, Isaacson PG. Relationship between high-grade lymphoma and low-grade B-cell mucosa-associated lymphoid tissue lymphoma (MALToma) of the stomach. Am J Pathol1990; 136:1153\u20131164."},{"key":"2019111715212156400_B11","doi-asserted-by":"crossref","unstructured":"Hans CP, Weisenburger DD, Greiner TC, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood2004; 103:275\u2013282.","DOI":"10.1182\/blood-2003-05-1545"},{"key":"2019111715212156400_B12","doi-asserted-by":"crossref","unstructured":"Bahler DW and Swerdlow SH. Clonal salivary gland infiltrates associated with myoepithelial sialadenitis (Sjogren's syndrome) begin as nonmalignant antigen-selected expansions. Blood1998; 91:1864\u20131872.","DOI":"10.1182\/blood.V91.6.1864"},{"key":"2019111715212156400_B13","unstructured":"Universite\u0301 Montpellier II, Centre National de la Recherche Scientifique. IMGT: ImMunoGeneTics. 2006; http:\/\/www.ebi.ac.uk\/imgt\/ Accessed September 16."},{"key":"2019111715212156400_B14","doi-asserted-by":"crossref","unstructured":"Tsuji S, Hisaoka M, Morimitsu Y, et al. Detection of SYT-SSX fusion transcripts in synovial sarcoma by reverse transcription-polymerase chain reaction using archival paraffin-embedded tissues. Am J Pathol1998; 153:1807\u20131812.","DOI":"10.1016\/S0002-9440(10)65695-7"},{"key":"2019111715212156400_B15","doi-asserted-by":"crossref","unstructured":"Greiner A, Tobollik S, Buettner M, et al. Differential expression of activation-induced cytidine deaminase (AID) in nodular lymphocyte-predominant and classical Hodgkin lymphoma. J Pathol2005; 205:541\u2013547.","DOI":"10.1002\/path.1746"},{"key":"2019111715212156400_B16","unstructured":"Yano T, Sander CA, Clark HM, Dolezal MV, Jaffe ES, Raffeld M. Clustered mutations in the second exon of the MYC gene in sporadic Burkitt's lymphoma. Oncogene1993; 8:2741\u20132748."},{"key":"2019111715212156400_B17","doi-asserted-by":"crossref","unstructured":"Dang CV. c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol1999; 19:1\u201311.","DOI":"10.1128\/MCB.19.1.1"},{"key":"2019111715212156400_B18","doi-asserted-by":"crossref","unstructured":"Raffeld M, Yano T, Hoang AT, et al. Clustered mutations in the transcriptional activation domain of Myc in 8q24 translocated lymphomas and their functional consequences. Curr Top Microbiol Immunol1995; 194:265\u2013272.","DOI":"10.1007\/978-3-642-79275-5_31"},{"key":"2019111715212156400_B19","doi-asserted-by":"crossref","unstructured":"Cesarman E, Dalla-Favera R, Bentley D, Groudine M. Mutations in the first exon are associated with altered transcription of c-myc in Burkitt lymphoma. Science1987; 238:1272\u20131275.","DOI":"10.1126\/science.3685977"},{"key":"2019111715212156400_B20","doi-asserted-by":"crossref","unstructured":"Lossos IS, Levy R, Alizadeh AA. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity. Leukemia2004; 18:1775\u20131779.","DOI":"10.1038\/sj.leu.2403488"},{"key":"2019111715212156400_B21","doi-asserted-by":"crossref","unstructured":"Pasqualucci L, Guglielmino R, Houldsworth J, et al. Expression of the AID protein in normal and neoplastic B cells. Blood2004; 104:3318\u20133325.","DOI":"10.1182\/blood-2004-04-1558"},{"key":"2019111715212156400_B22","doi-asserted-by":"crossref","unstructured":"Greeve J, Philipsen J, Krause K, et al. Expression of activation-induced cytidine deaminase in human B-cell non-Hodgkin lymphomas. Blood2003; 101:3574\u20133580.","DOI":"10.1182\/blood-2002-08-2424"},{"key":"2019111715212156400_B23","doi-asserted-by":"crossref","unstructured":"Montesinos-Rongen M, Van Roost D, Schaller C, Wiestler OD, Deckert M. Primary diffuse large B-cell lymphomas of the central nervous system are targeted by aberrant somatic hypermutation. Blood2004; 103:1869\u20131875.","DOI":"10.1182\/blood-2003-05-1465"},{"key":"2019111715212156400_B24","doi-asserted-by":"crossref","unstructured":"Rossi D, Cerri M, Capello D, et al. Aberrant somatic hypermutation in primary mediastinal large B-cell lymphoma. Leukemia2005; 19:2363\u20132366.","DOI":"10.1038\/sj.leu.2403982"},{"key":"2019111715212156400_B25","doi-asserted-by":"crossref","unstructured":"Reiniger L, Bodor C, Bognar A, et al. Richter's and prolymphocytic transformation of chronic lymphocytic leukemia are associated with high mRNA expression of activation-induced cytidine deaminase and aberrant somatic hypermutation. Leukemia2006:1089\u20131095.","DOI":"10.1038\/sj.leu.2404183"},{"key":"2019111715212156400_B26","doi-asserted-by":"crossref","unstructured":"Deutsch A, Aigelsreiter A, Beham-Schmid C, Beham A, Linkesch W, Neumeister P. Aberrant somatic hypermutation in extranodal marginal zone B-cell lymphoma of MALT type [abstract]. Blood2005; 106: Abstract 417.","DOI":"10.1182\/blood.V106.11.417.417"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/8\/3500\/1291041\/zh800807003500.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/109\/8\/3500\/1291041\/zh800807003500.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T11:21:47Z","timestamp":1587295307000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/109\/8\/3500\/23702\/MALT-lymphoma-and-extranodal-diffuse-large-Bcell"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,12,29]]},"references-count":26,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2006,12,29]]},"published-print":{"date-parts":[[2007,4,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2006-06-030494","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,12,29]]}}}